Title 8. DRUG UTILISATION EVALUATION (DUE) AND REVIEW (DUR).pdf ✅

PHARMD GURU Page 1 DRUG UTILISATION EVALUATION (DUE) According to WHO, Drug Utilization evaluation is defined as the marketing, distribution, prescription and use of drugs in society, with special emphasis on the resulting medical, social and economic consequences. Drug Utilization Evaluation (DUE) is an ongoing authorized and systematic quality improvement process, designed to:  To optimize drug use by developing criteria and standards.  To educate clinicians and other Health Care Professionals (HCP), to increase appropriate drug use.  To provide feedback of results obtained during study to clinicians and other HCP.  To review drug use.  To analyze prescription pattern. TYPES OF DUE: 1) Quantitative DUE studies. 2) Qualitative DUE studies. DUE COMMITTEE:  DUE Committee should be composed of physicians, pharmacists and other relevant health-care professionals.  The committee must include professionals with on interest in improving drug therapy in the hospital and have ready access to experts in the medicine, surgery and major hospital specialists.  Pharmacists generally play a major role in the delivery of DUE and it is usual for the committee to include pharmacy department representation. ROLE OF PHARMACIST IN DUE:  Planning, organizing and implementing a DUE program.  Program, development, supervision and coordination.  Education of hospital staff about DUE in conceptual an practical terms. DRUG UTILISATION EVALUATION (DUE) AND REVIEW (DUR)